Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness
This study has been completed.
Sponsors and Collaborators: The University of New South Wales
Australian Government Department of Health and Ageing
Information provided by: The University of New South Wales
ClinicalTrials.gov Identifier: NCT00350493
  Purpose

This is a three year follow up of a previous study where researchers at UNSW and UNewc asked smokers with serious mental health problems to participate in a 12-month study, to assess whether intervention could assist people experiencing mental illness reduce their tobacco smoking.


Condition Phase
Psychotic Disorder
Behavior, Addictive
Phase IV

MedlinePlus related topics: Mental Health Psychotic Disorders
U.S. FDA Resources
Study Type: Observational
Official Title: Three Year Follow up of a Randomised Controlled Trial of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness

Further study details as provided by The University of New South Wales:

Estimated Enrollment: 298
Study Start Date: January 2005
Study Completion Date: February 2006
Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Between 2001 and 2003, the School of Public Health and Community Medicine at the University of New South Wales carried out a large study with the Centre for Mental Health Studies at the University of Newcastle. The project asked people with serious mental health problems, who also smoked cigarettes, to participate in a 12-month study, which involved completing several questionnaires/other assessments over that time with a member of the research team. Around half of the participants in this study also received treatment for their smoking from the research team. This treatment involved weekly therapy with one member of the research team, and covered the relationship between smoking and mental illness, teaching people to cope with desires to smoke, how to recognise and avoid high risk situations for smoking, and how to plan alternative ways of coping with those situations where smoking usually occurred. In addition, nicotine patches were also available to assist people who made the decision to reduce their smoking. This study hoped to learn whether this new treatment could assist people experiencing mental illness reduce their tobacco smoking.

After three years, previous participants were invited to participate in another follow-up assessment to check-in with their current situation, their mental health and levels of smoking.

  Eligibility

Ages Eligible for Study:   18 Years to 67 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Previous participants from the original study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00350493

Locations
Australia, New South Wales
School of Public Health and Community Medicine, University of New South Wales
Sydney, New South Wales, Australia, 2052
Centre for Mental Health Studies, University of Newcastle
Newcastle, New South Wales, Australia, 2308
Sponsors and Collaborators
The University of New South Wales
Australian Government Department of Health and Ageing
Investigators
Principal Investigator: Robyn Richmond, Professor University of New South Wales
Principal Investigator: Amanda Baker, Assoc Prof University of Newcastle
  More Information

Study ID Numbers: 3Yr FollowUp
Study First Received: July 6, 2006
Last Updated: September 25, 2008
ClinicalTrials.gov Identifier: NCT00350493  
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration

Study placed in the following topic categories:
Schizophrenia
Compulsive Behavior
Behavior, Addictive
Mental Disorders
Tobacco Use Disorder
Substance-Related Disorders
Disorders of Environmental Origin
Psychotic Disorders
Impulsive Behavior
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on January 14, 2009